XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Income Statement [Abstract]        
Net sales $ 6,696,187 $ 13,832,780 $ 24,642,728 $ 39,995,803
Cost of goods sold 9,694,096 10,749,970 24,545,534 30,182,996
Gross profit (2,997,909) 3,082,810 97,194 9,812,807
Operating expenses:        
Selling and marketing 2,073,636 3,802,735 9,386,157 11,286,370
General and administrative 963,108 1,922,315 3,460,092 4,991,959
Research and development 687,076 1,310,300 3,358,276 4,227,290
Total operating expenses 3,723,820 7,035,350 16,204,525 20,505,619
Operating loss (6,721,729) (3,952,540) (16,107,331) (10,692,812)
Other expense:        
Interest expense, net 99,084 93,733 356,644 261,802
Total other expense 99,084 93,733 356,644 261,802
Loss before income taxes (6,820,813) (4,046,273) (16,463,974) (10,954,614)
Income taxes (benefit) (525) 16,307 24,451 73,026
Net loss $ (6,820,287) $ (4,062,580) $ (16,488,425) $ (11,027,640)
Net loss per share:        
Net loss per share, Basic $ (3.61) $ (2.18) $ (8.74) $ (5.95)
Net loss per share, Diluted $ (3.61) $ (2.18) $ (8.74) $ (5.95)
Basic weighted average common and common equivalent shares 1,890,933 1,861,090 1,886,465 1,851,916
Diluted weighted average common and common equivalent shares 1,890,933 1,861,090 1,886,465 1,851,916